The Beroukhim Lab recently published the largest clinical study to date of genetic abnormalities in pediatric brain tumors, demonstrating that testing pediatric brain tumor tissue for genetic abnormalities is clinically feasible and can guide patients’ treatment. Neuro-Oncology, May 2017.